Review of NVP and HG and Early Pharmacotherapeutic Intervention
NVP occurs in 50–90% of pregnancies, making it a common medical condition in pregnancy. Women present differently with any combination of signs and symptoms. It is appropriate to take the pregnancy-related versus nonpregnancy-related approach when determining the cause of nausea and vomiting but oth...
Saved in:
Main Authors: | Shannon M. Clark, Maged M. Costantine, Gary D. V. Hankins |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Obstetrics and Gynecology International |
Online Access: | http://dx.doi.org/10.1155/2012/252676 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Comprehensive Review on Pharmacotherapeutics of Herbal Bioenhancers
by: Ghanshyam B. Dudhatra, et al.
Published: (2012-01-01) -
An Insight into Potential Pharmacotherapeutic Agents for Painful Diabetic Neuropathy
by: Zunaira Qureshi, et al.
Published: (2022-01-01) -
Pharmacotherapeutic Options for Managing Neuropathic Pain: A Systematic Review and Meta-Analysis
by: Giulia Di Stefano, et al.
Published: (2021-01-01) -
Impact of Novel Resistance Profiles in HIV-1 Reverse Transcriptase on Phenotypic Resistance to NVP
by: Liyan Jiao, et al.
Published: (2012-01-01) -
Possible erythropoietin pharmacotherapeutic targets on painful diabetic neuropathy in rats
by: SAMUEL SUAREZ-MENDEZ, et al.
Published: (2025-02-01)